Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness
Diabetes mellitus complicated with cerebral infarction (DMCI) has a high incidence and disability rate. Therefore, identification of biomarkers for the early prediction of the development and progression of cerebral infarction (CI) is of great significance for the prevention and treatment of this di...
Gespeichert in:
| Veröffentlicht in: | Experimental and therapeutic medicine 2020-02, Vol.19 (2), p.1167-1174 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1174 |
|---|---|
| container_issue | 2 |
| container_start_page | 1167 |
| container_title | Experimental and therapeutic medicine |
| container_volume | 19 |
| creator | Dai, Zhenxiang Jiao, Yang Fan, Qingxian Qi, Anning Xiao, Liang Li, Jingwei |
| description | Diabetes mellitus complicated with cerebral infarction (DMCI) has a high incidence and disability rate. Therefore, identification of biomarkers for the early prediction of the development and progression of cerebral infarction (CI) is of great significance for the prevention and treatment of this disease. The roles of serum homocysteine (Hey), interleukin-1β (IL-1β), and fasting blood glucose (FBG) in DMCI and their correlations with carotid intima-media thickness (CIMT) were explored. A total of 124 patients with DMCI (DMCI group) and 103 patients with diabetes mellitus (DM) (DM group) admitted to the People's Hospital of Liuhe District of Nanjing were enrolled in this study. A further 100 healthy controls undergoing physical examinations during the same period (HC group) were also enrolled. CIMT value was detected by carotid artery ultrasound. Hey and FBG levels were determined by a fully automatic biochemical analyzer. The IL-1β level was detected by enzyme-linked immunosorbent assay (ELISA). The levels of Hey, IL-1β, and FBG and the CIMT value in the DMCI and DM groups were significantly higher than those in the HC group (P |
| doi_str_mv | 10.3892/etm.2019.8326 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6966155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2350372073</sourcerecordid><originalsourceid>FETCH-LOGICAL-c345t-8007a1383f766335da8b5d448826ea87140a9aae24e4e64104fdda90bf5eabaa3</originalsourceid><addsrcrecordid>eNpdksFu1DAQhiMEolXpkSuyxIVDs9ixnTgXJFQBrVSJC5ytiTPZddexF9tp1dfiFbjzTHjptir4Ykvz-Z9_7L-qXjO64qpv3mOeVw1l_Urxpn1WHbOub2pGmXx-ONNesaPqNKVrWpZsmVLyZXXEyyXaKHlc_boIczB3KaP1eEaszxgdLlvra_b75xkBP5IJUrZ-TQYXwkjWbjEhIXF4gy4RSGQXw9qHwhgyQ9xiTGQKkYwWBsyYyIzO2bwkYsK8c9ZAxpHc2rwhBiMOEVzpO0E02Qb_t6MJMaJ7wkEM2Y57e3aGesaiTfLGmq3HlF5VLyZwCU8P-0n1_fOnb-cX9dXXL5fnH69qw4XMtaK0A8YVn7q25VyOoAY5CqFU0yKojgkKPQA2AgW2glExjSP0dJgkwgDAT6oP97q7ZSgWDPpcvOtdLJ7inQ5g9b8Vbzd6HW5027ctk7IIvDsIxPBjwZT1bJMprwMew5J0wyXlXUM7XtC3_6HXYYm-jFcowUT53bYrVH1PmRhSijg9mmFU7xOiS0L0PiF6n5DCv3k6wSP9kAf-B7Ytvfk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2341417967</pqid></control><display><type>article</type><title>Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness</title><source>PubMed Central</source><creator>Dai, Zhenxiang ; Jiao, Yang ; Fan, Qingxian ; Qi, Anning ; Xiao, Liang ; Li, Jingwei</creator><creatorcontrib>Dai, Zhenxiang ; Jiao, Yang ; Fan, Qingxian ; Qi, Anning ; Xiao, Liang ; Li, Jingwei</creatorcontrib><description><![CDATA[Diabetes mellitus complicated with cerebral infarction (DMCI) has a high incidence and disability rate. Therefore, identification of biomarkers for the early prediction of the development and progression of cerebral infarction (CI) is of great significance for the prevention and treatment of this disease. The roles of serum homocysteine (Hey), interleukin-1β (IL-1β), and fasting blood glucose (FBG) in DMCI and their correlations with carotid intima-media thickness (CIMT) were explored. A total of 124 patients with DMCI (DMCI group) and 103 patients with diabetes mellitus (DM) (DM group) admitted to the People's Hospital of Liuhe District of Nanjing were enrolled in this study. A further 100 healthy controls undergoing physical examinations during the same period (HC group) were also enrolled. CIMT value was detected by carotid artery ultrasound. Hey and FBG levels were determined by a fully automatic biochemical analyzer. The IL-1β level was detected by enzyme-linked immunosorbent assay (ELISA). The levels of Hey, IL-1β, and FBG and the CIMT value in the DMCI and DM groups were significantly higher than those in the HC group (P<0.001). The levels and the value in the DMCI group were significantly higher than those in the DM group (P<0.001). Hey, IL-1β, and FBG levels were positively correlated with CIMT value (r=0.542, P<0.001; r=0.522, P<0.001; r=0.402, P<0.001). Receiver operating characteristic (ROC) curves showed that the sensitivity and specificity of Hey for diagnosing DMCI were 86.29 and 80.58%; those of IL-1β were 68.55 and 86.41%; those of FBG were 69.35 and 88.35%. Multivariate logistic regression analysis revealed that systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), Hey, IL-1β, FBG, and CIMT were independent risk factors for DMCI (P<0.05). In conclusion, patients with DMCI have severe atherosclerosis. Hey, IL-1β, and FBG are involved in the development and progression of DMCI, so they can be used as predictive markers for the disease. Hey, IL-1β, FBG, and CIMT are independent risk factors for patients with DMCI.]]></description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2019.8326</identifier><identifier>PMID: 32010285</identifier><language>eng</language><publisher>Greece: Spandidos Publications UK Ltd</publisher><subject>Age ; Apolipoproteins ; Atherosclerosis ; Blood pressure ; Cardiovascular disease ; Carotid arteries ; Cholesterol ; Cytokines ; Diabetes ; Enzymes ; Fasting ; Homocysteine ; Medical prognosis ; Metabolism ; Statistical analysis ; Stroke ; Thrombosis ; Veins & arteries</subject><ispartof>Experimental and therapeutic medicine, 2020-02, Vol.19 (2), p.1167-1174</ispartof><rights>Copyright: © Dai et al.</rights><rights>Copyright Spandidos Publications UK Ltd. 2020</rights><rights>Copyright: © Dai et al. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c345t-8007a1383f766335da8b5d448826ea87140a9aae24e4e64104fdda90bf5eabaa3</citedby><cites>FETCH-LOGICAL-c345t-8007a1383f766335da8b5d448826ea87140a9aae24e4e64104fdda90bf5eabaa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966155/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966155/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32010285$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dai, Zhenxiang</creatorcontrib><creatorcontrib>Jiao, Yang</creatorcontrib><creatorcontrib>Fan, Qingxian</creatorcontrib><creatorcontrib>Qi, Anning</creatorcontrib><creatorcontrib>Xiao, Liang</creatorcontrib><creatorcontrib>Li, Jingwei</creatorcontrib><title>Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description><![CDATA[Diabetes mellitus complicated with cerebral infarction (DMCI) has a high incidence and disability rate. Therefore, identification of biomarkers for the early prediction of the development and progression of cerebral infarction (CI) is of great significance for the prevention and treatment of this disease. The roles of serum homocysteine (Hey), interleukin-1β (IL-1β), and fasting blood glucose (FBG) in DMCI and their correlations with carotid intima-media thickness (CIMT) were explored. A total of 124 patients with DMCI (DMCI group) and 103 patients with diabetes mellitus (DM) (DM group) admitted to the People's Hospital of Liuhe District of Nanjing were enrolled in this study. A further 100 healthy controls undergoing physical examinations during the same period (HC group) were also enrolled. CIMT value was detected by carotid artery ultrasound. Hey and FBG levels were determined by a fully automatic biochemical analyzer. The IL-1β level was detected by enzyme-linked immunosorbent assay (ELISA). The levels of Hey, IL-1β, and FBG and the CIMT value in the DMCI and DM groups were significantly higher than those in the HC group (P<0.001). The levels and the value in the DMCI group were significantly higher than those in the DM group (P<0.001). Hey, IL-1β, and FBG levels were positively correlated with CIMT value (r=0.542, P<0.001; r=0.522, P<0.001; r=0.402, P<0.001). Receiver operating characteristic (ROC) curves showed that the sensitivity and specificity of Hey for diagnosing DMCI were 86.29 and 80.58%; those of IL-1β were 68.55 and 86.41%; those of FBG were 69.35 and 88.35%. Multivariate logistic regression analysis revealed that systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), Hey, IL-1β, FBG, and CIMT were independent risk factors for DMCI (P<0.05). In conclusion, patients with DMCI have severe atherosclerosis. Hey, IL-1β, and FBG are involved in the development and progression of DMCI, so they can be used as predictive markers for the disease. Hey, IL-1β, FBG, and CIMT are independent risk factors for patients with DMCI.]]></description><subject>Age</subject><subject>Apolipoproteins</subject><subject>Atherosclerosis</subject><subject>Blood pressure</subject><subject>Cardiovascular disease</subject><subject>Carotid arteries</subject><subject>Cholesterol</subject><subject>Cytokines</subject><subject>Diabetes</subject><subject>Enzymes</subject><subject>Fasting</subject><subject>Homocysteine</subject><subject>Medical prognosis</subject><subject>Metabolism</subject><subject>Statistical analysis</subject><subject>Stroke</subject><subject>Thrombosis</subject><subject>Veins & arteries</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdksFu1DAQhiMEolXpkSuyxIVDs9ixnTgXJFQBrVSJC5ytiTPZddexF9tp1dfiFbjzTHjptir4Ykvz-Z9_7L-qXjO64qpv3mOeVw1l_Urxpn1WHbOub2pGmXx-ONNesaPqNKVrWpZsmVLyZXXEyyXaKHlc_boIczB3KaP1eEaszxgdLlvra_b75xkBP5IJUrZ-TQYXwkjWbjEhIXF4gy4RSGQXw9qHwhgyQ9xiTGQKkYwWBsyYyIzO2bwkYsK8c9ZAxpHc2rwhBiMOEVzpO0E02Qb_t6MJMaJ7wkEM2Y57e3aGesaiTfLGmq3HlF5VLyZwCU8P-0n1_fOnb-cX9dXXL5fnH69qw4XMtaK0A8YVn7q25VyOoAY5CqFU0yKojgkKPQA2AgW2glExjSP0dJgkwgDAT6oP97q7ZSgWDPpcvOtdLJ7inQ5g9b8Vbzd6HW5027ctk7IIvDsIxPBjwZT1bJMprwMew5J0wyXlXUM7XtC3_6HXYYm-jFcowUT53bYrVH1PmRhSijg9mmFU7xOiS0L0PiF6n5DCv3k6wSP9kAf-B7Ytvfk</recordid><startdate>20200201</startdate><enddate>20200201</enddate><creator>Dai, Zhenxiang</creator><creator>Jiao, Yang</creator><creator>Fan, Qingxian</creator><creator>Qi, Anning</creator><creator>Xiao, Liang</creator><creator>Li, Jingwei</creator><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200201</creationdate><title>Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness</title><author>Dai, Zhenxiang ; Jiao, Yang ; Fan, Qingxian ; Qi, Anning ; Xiao, Liang ; Li, Jingwei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c345t-8007a1383f766335da8b5d448826ea87140a9aae24e4e64104fdda90bf5eabaa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age</topic><topic>Apolipoproteins</topic><topic>Atherosclerosis</topic><topic>Blood pressure</topic><topic>Cardiovascular disease</topic><topic>Carotid arteries</topic><topic>Cholesterol</topic><topic>Cytokines</topic><topic>Diabetes</topic><topic>Enzymes</topic><topic>Fasting</topic><topic>Homocysteine</topic><topic>Medical prognosis</topic><topic>Metabolism</topic><topic>Statistical analysis</topic><topic>Stroke</topic><topic>Thrombosis</topic><topic>Veins & arteries</topic><toplevel>online_resources</toplevel><creatorcontrib>Dai, Zhenxiang</creatorcontrib><creatorcontrib>Jiao, Yang</creatorcontrib><creatorcontrib>Fan, Qingxian</creatorcontrib><creatorcontrib>Qi, Anning</creatorcontrib><creatorcontrib>Xiao, Liang</creatorcontrib><creatorcontrib>Li, Jingwei</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dai, Zhenxiang</au><au>Jiao, Yang</au><au>Fan, Qingxian</au><au>Qi, Anning</au><au>Xiao, Liang</au><au>Li, Jingwei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2020-02-01</date><risdate>2020</risdate><volume>19</volume><issue>2</issue><spage>1167</spage><epage>1174</epage><pages>1167-1174</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract><![CDATA[Diabetes mellitus complicated with cerebral infarction (DMCI) has a high incidence and disability rate. Therefore, identification of biomarkers for the early prediction of the development and progression of cerebral infarction (CI) is of great significance for the prevention and treatment of this disease. The roles of serum homocysteine (Hey), interleukin-1β (IL-1β), and fasting blood glucose (FBG) in DMCI and their correlations with carotid intima-media thickness (CIMT) were explored. A total of 124 patients with DMCI (DMCI group) and 103 patients with diabetes mellitus (DM) (DM group) admitted to the People's Hospital of Liuhe District of Nanjing were enrolled in this study. A further 100 healthy controls undergoing physical examinations during the same period (HC group) were also enrolled. CIMT value was detected by carotid artery ultrasound. Hey and FBG levels were determined by a fully automatic biochemical analyzer. The IL-1β level was detected by enzyme-linked immunosorbent assay (ELISA). The levels of Hey, IL-1β, and FBG and the CIMT value in the DMCI and DM groups were significantly higher than those in the HC group (P<0.001). The levels and the value in the DMCI group were significantly higher than those in the DM group (P<0.001). Hey, IL-1β, and FBG levels were positively correlated with CIMT value (r=0.542, P<0.001; r=0.522, P<0.001; r=0.402, P<0.001). Receiver operating characteristic (ROC) curves showed that the sensitivity and specificity of Hey for diagnosing DMCI were 86.29 and 80.58%; those of IL-1β were 68.55 and 86.41%; those of FBG were 69.35 and 88.35%. Multivariate logistic regression analysis revealed that systolic blood pressure (SBP), diastolic blood pressure (DBP), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), Hey, IL-1β, FBG, and CIMT were independent risk factors for DMCI (P<0.05). In conclusion, patients with DMCI have severe atherosclerosis. Hey, IL-1β, and FBG are involved in the development and progression of DMCI, so they can be used as predictive markers for the disease. Hey, IL-1β, FBG, and CIMT are independent risk factors for patients with DMCI.]]></abstract><cop>Greece</cop><pub>Spandidos Publications UK Ltd</pub><pmid>32010285</pmid><doi>10.3892/etm.2019.8326</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1792-0981 |
| ispartof | Experimental and therapeutic medicine, 2020-02, Vol.19 (2), p.1167-1174 |
| issn | 1792-0981 1792-1015 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6966155 |
| source | PubMed Central |
| subjects | Age Apolipoproteins Atherosclerosis Blood pressure Cardiovascular disease Carotid arteries Cholesterol Cytokines Diabetes Enzymes Fasting Homocysteine Medical prognosis Metabolism Statistical analysis Stroke Thrombosis Veins & arteries |
| title | Homocysteine, interleukin-1β, and fasting blood glucose levels as prognostic markers for diabetes mellitus complicated with cerebral infarction and correlated with carotid intima-media thickness |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A39%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Homocysteine,%20interleukin-1%CE%B2,%20and%20fasting%20blood%20glucose%20levels%20as%20prognostic%20markers%20for%20diabetes%20mellitus%20complicated%20with%20cerebral%20infarction%20and%20correlated%20with%20carotid%20intima-media%20thickness&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Dai,%20Zhenxiang&rft.date=2020-02-01&rft.volume=19&rft.issue=2&rft.spage=1167&rft.epage=1174&rft.pages=1167-1174&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2019.8326&rft_dat=%3Cproquest_pubme%3E2350372073%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2341417967&rft_id=info:pmid/32010285&rfr_iscdi=true |